Newsletter - All News

Newsletter- All News is a comprehensive section of updated news and current trends, specifically curated to keep clinical trials, including breakthroughs in drug research, regulatory approvals, and advancements in study methodologies. Our news covers key trends in trial designs, patient recruitment strategies, and cutting-edge technologies shaping the future of clinical research

Category

Continent

From

To

AstraZeneca’s Saphnelo Hits Key Milestone in Subcu...

AstraZeneca’s Saphnelo Hits Key Milestone in Subcu...

Category : Clinical Trial Update 18 September 2025

AstraZeneca announced positive interim results from the phase III TULIP-SC trial of Saphnelo (anifro...

CorestemChemon Presents Phase 3 ALSummit Trial Res...

CorestemChemon Presents Phase 3 ALSummit Trial Res...

Category : Clinical Trial Update 18 September 2025

CorestemChemon Inc. (KOSDAQ: 166480) presented results from the Phase 3 ALSummit trial of Neuronata-...

RemeGen’s Telitacicept OLE Data Selected for Oral...

RemeGen’s Telitacicept OLE Data Selected for Oral...

Category : Clinical Trial Update 18 September 2025

RemeGen (688331.SH/09995.HK) announced that 48-week open-label extension (OLE) results of telitacice...

Ascletis Presents Phase III Results of Denifanstat...

Ascletis Presents Phase III Results of Denifanstat...

Category : Clinical Trial Update 18 September 2025

Ascletis Pharma Inc. (HKEX: 1672) presented Phase III results of denifanstat (ASC40) in moderate to...

MagicRNA Publishes First Clinical Data of In Vivo...

MagicRNA Publishes First Clinical Data of In Vivo...

Category : Clinical Trial Update 18 September 2025

MagicRNA, a clinical-stage biotech pioneering in vivo CAR T-cell therapies, announced the publicatio...

1
2
›

Subscribe to Our Newsletter!

Subscribe to get latest updates and information.